Endo International to buy Par Pharmaceutical for about $8 billion: Reuters

Endo International Plc (ENDP.O) said it would buy Par Pharmaceutical Holdings Inc from private equity firm TPG Capital for about $8 billion, including debt, to become a top-five global generic drugmaker, Reuters News reported.

DealsNorth AmericaUSBriefs